Bladder cancer is a heterogeneous disease with a variable natural history. At one end of the
spectrum, low-grade Ta tumors have a low progression rate and require initial endoscopic …

While patient age and gender are important factors in the clinical decision‐making for
treating urothelial carcinoma of the bladder (UCB), there are no evidence‐based …

EUROCARE-4 analysed about three million adult cancer cases from 82 cancer registries in
23 European countries, diagnosed in 1995–1999 and followed to December 2003. For each …

ABSTRACT EUROCARE-3 analysed the survival of 1815584 adult cancer patients
diagnosed from 1990 to 1994 in 22 European countries. The results are reported in tables …

PURPOSE: To examine the overall and stage-specific age-adjusted incidence, 5-year
survival and mortality rates of bladder cancer (BCa) in the United States, between 1973 and …

BACKGROUND: Controversy exists over the most important prognostic factors in T1 high-
grade non–muscle-invasive bladder cancer (NMIBC) patients treated with bacillus Calmette …

BACKGROUD: Sex, race, and age at diagnosis have a significant impact on mortality from
bladder cancer (BC). Women, African Americans of both sexes, and the elderly, all …

Introduction While patient gender is an important factor in the clinical decision-making for the
management of bladder cancer, there are minimal evidence-based recommendations to …

Background: Bladder cancer (BC) predominantly affects the elderly and is often the cause of
death among patients with muscle-invasive disease. Clinicians lack quantitative estimates of …

BACKGROUND Women have disproportionately higher mortality rates relative to incidence
for bladder cancer. Multiple etiologies have been proposed, including delayed diagnosis …